Rutgers Study Identifies Potential Treatment for Inflammatory Bowel Disease
May 11, 2022
May 11, 2022
NEW BRUNSWICK, New Jersey, May 11 (TNSJou) -- Rutgers University issued the following news:
Researchers at Rutgers Robert Wood Johnson Medical School have identified immune cells in the intestine that are needed to prevent Inflammatory Bowell Disease (IBD), Colitis and Chron's disease, which affects three million people in the United States.
The Rutgers researchers have been studying the immune response to IBD for the past decade. In a study, published in Science I . . .
Researchers at Rutgers Robert Wood Johnson Medical School have identified immune cells in the intestine that are needed to prevent Inflammatory Bowell Disease (IBD), Colitis and Chron's disease, which affects three million people in the United States.
The Rutgers researchers have been studying the immune response to IBD for the past decade. In a study, published in Science I . . .